Allergic contact dermatitis (ACD) is one of the most prevalent skin diseases. It is caused by a T cell-mediated delayed-type contact hypersensitivity (CHS) reaction that develops after repeated skin exposure to low-molecular-weight chemicals called haptens that are present in skin care products, fragrances, and hair dyes. 1 Haptens are also present as additives in processed food, formula milk, and antibiotics, consumption of which have increased in Western life along with the increase in food allergies because of breakdown of tolerance. After binding to self-proteins or exogenous proteins, haptens become immunogenic and are presented to T cells, leading to the differentiation of IFN-g-producing cytotoxic CD8 1 effector T cells responsible for induction of CHS lesions. 2 Robust immunoregulatory mechanisms called oral tolerance are initiated in the intestine and inhibit the development of T cell-mediated delayed-type hypersensitivity (DTH) responses to dietary proteins 3 and haptens, [4] [5] [6] resulting in prevention of allergic and inflammatory reactions both within the gut and at remote skin sites. Clinical studies in healthy human volunteers have documented that oral pre-exposure to a protein 7 or a hapten 8 before skin exposure to the same antigen prevents DTH responses, including ACD.
Most of our current knowledge on the mechanism of oral tolerance derives from studies using ovalbumin (OVA) as a model protein antigen and T-cell receptor transgenic mice. These studies have shown that oral tolerance is mediated by forkhead box p3 (Foxp3)
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CD4
1 regulatory T (Treg) cells induced by antigen gavage, which suppress specific T-cell priming and DTH responses. 9 Tolerance critically relies on intestinal CD103
1 dendritic cells (DCs) that transport the oral antigen from the lamina propria to the draining mesenteric lymph nodes (MLN) 10 and convert conventional CD4 1 T cells into suppressive Foxp3
1 Treg cells, 11, 12 alleviating allergic and inflammatory responses. 9 We showed earlier, with the widely used model of CHS to 2,4-dinitro-fluorobenzene (DNFB), which reproduces the pathophysiology of human ACD, that oral tolerance to 1 effector cells and prevent development of skin inflammation. [4] [5] [6] The intestinal microbiota is essential for the maintenance of local and systemic homeostasis and greatly conditions susceptibility to various pathologies, including inflammatory and allergic diseases. Such a critical role largely relies on its capacity to regulate cells of the immune system. Gut microbial products and metabolites indeed influence the functional diversity and repertoire of adaptive immune cells, including T H 17 and Treg cells, 13 and shape myeloid cell migration and functions.
14 Such host/microbiome communication involves sensing of microbial products and metabolites by pattern recognition receptors, including Toll-like receptors (TLRs) and NOD-like receptors expressed by intestinal epithelial and hematopoietic cells. 14, 15 Various studies in germ-free (GF) mice and TLRdeficient mice indicate that the microbiota and LPS sensing by TLR4 are instrumental for tolerance induction to dietary protein antigens 16, 17 and for prevention of oral sensitization. 18, 19 In addition, TLR signaling in small intestinal epithelial cells was shown to promote sampling of luminal antigen by lamina propria macrophages, 20 which transfer dietary proteins to CD103 1 DC for tolerance induction. 21 However, whether the gut microbiota and TLRs contribute to oral tolerance to haptens remains poorly studied.
We previously documented that oral probiotic treatment alleviates the CHS response to DNFB by acting on both effector and Treg cells, suggesting that commensal bacteria in the gut can regulate immune responses at a remote (skin) site. 22, 23 In the present study we show that the presence of a normal flora or TLR4 is crucial for induction of oral tolerance and suppression of CHS responses and that TLR4 licenses tolerogenic intestinal DCs and their ability to induce Foxp3 1 Treg conversion in the presence of latent TGF-b.
METHODS Mice
Six-to 10-week-old specific pathogen-free (SPF) and GF C3H/HeN mice were bred in pathogen-free Texler-type isolators (La Calh ene, V elizy, France) and fed ad libitum under sterile conditions at the animal facility of the MICALIS institute (INRA, Jouy-en-Josas, France). CD45.2 C57BL/6 (B6) and CD45.1 (Ly5a) congenic mice were purchased from Charles Rivers Laboratories (L'Arbresle, France). TLR2 Oral tolerance in the model of DNFB-specific CHS Mice were orally tolerized by means of a single intragastric administration of 300 mL of 0.1% DNFB (Sigma, St Quentin Fallavier, France) in acetone/ olive oil (1:10 vol/vol) 7 days before skin painting with 25 mL of 0.5% DNFB diluted in acetone/olive oil (4:1 vol/vol). Mice were challenged 5 days later with 4 mL of 0.15% DNFB applied onto each side of the right ear, and the CHS was determined by using the mouse ear-swelling test, as previously described. 5 
IFN-g ELISpot
The frequency of hapten-specific IFN-g-producing T cells was determined on day 5 after skin DNFB sensitization by using the ELISpot assay, as previously described. 6 Briefly, serial numbers of either total or purified CD8 
Flow cytometry
Anti-CD3ε (500A2), anti-CD4 (RM4-5), anti-CD11b (M1/70), anti-CD11c (HL3 and N418), anti-CD45.2 (104), and anti-CD103 (M290) antibodies and matching isotype controls were purchased from BD PharMingen (San Diego, Calif). Anti-CD45.1 (A20) and anti-MHC-II (I-A/I-E: M5/114.15.2) antibodies were from BioLegend (San Diego, Calf), and anti-NKp46 (29A1.4) was from eBioscience (San Diego, Calif). The Foxp3 staining kit from eBioscience was used to detect intranuclear Foxp3. The cell activity of retinaldehyde dehydrogenase (RALDH) was determined by using the ALDEFLUOR staining kit (STEMCELL Technologies, Vancouver, British Columbia, Canada), as previously described. 24 Fluorescence-activated cell sorting (FACS) analysis was performed with a FACSCanto system or LRSII (BD Biosciences, Le Pont de Claix, France), and analyses were performed with FlowJo software (TreeStar, Ashland, Ore).
Generation of bone marrow chimeric mice
Eight-to 10-week-old B6 Ly5a (CD45.1
were given 2 lethal whole-body irradiations of 5 Gy 4 hours apart and were injected intravenously 6 hours later with 10 7 bone marrow (BM) cells from either B6 Ly5a or TLR4 2/2 mice. Ten weeks after transplantation, chimerism, as assessed by using FACS analysis with anti-CD45.1 and anti-CD45.2 antibodies, showed greater than 99% B cells of donor origin in blood, peripheral lymph nodes (LNs), MLNs, and the spleen. 2/2 were transferred subcutaneously to B6 recipient mice. Seven days later, all mice were skin sensitized with DNFB, and the frequency of IFN-g 1 CD8 1 T cells in skin draining lymph nodes (dLNs) was assessed by using the IFN-g ELISpot assay.
Adoptive transfer of DCs
In some experiments mice were ear challenged with DNFB 5 days after sensitization, and the CHS response was determined based on ear swelling. 2 ) cells by using anti-CD11b-allophycocyanin-eFluor780 (eBioscience), anti-CD11c-allophycocyanin, and anti-CD103-phycoerythrin (both from PharMingen). DCs were irradiated at 30 Gy and cocultured at various DC/T-cell ratios for 3 days at 378C with DNFB-specific CD8 
Statistics
The nonparametric Mann-Whitney U test was used to compare 2 experimental groups. For comparison of 3 or more experimental groups, 1-way ANOVA with Bonferroni correction or Kruskal-Wallis tests was used in accordance with experimental settings. The Dunn multiple comparison test was used to generate P values for selected pairwise comparisons. GraphPad Prism 5.0 software (GraphPad Software, San Diego, Calif) was used for statistical analysis.
RESULTS
Oral tolerance to DNFB is impaired in GF mice
The efficacy of DNFB gavage to inhibit the CHS response to DNFB was compared in SPF and GF mice to determine whether oral tolerance requires the microbiota. As expected from our previous studies, 4, 5, 25 DNFB gavage of SPF mice completely prevented the CHS response, whereas vehicle-fed control mice experienced an ear swelling that peaked at 24 to 48 hours after challenge and progressively resolved thereafter (Fig 1) . The CHS response in vehicle-fed control GF mice was comparable in intensity and kinetics to that of SPF mice. In contrast, DNFB gavage of GF mice resulted only in a modest and nonsignificant decrease in the CHS response, which still was not resolved by day 4 (Fig 1) . Thus lack of the microbiota dramatically impaired induction of oral tolerance to DNFB.
Oral tolerance to DNFB is abrogated in TLR4
2/2 mice Because sensing of the microbiota largely depends on TLRs, we next tested whether oral tolerance was affected in mice deficient in TLR2, TLR4, or TLR9. A comparable CHS response to DNFB developed in B6 mice and TLR2, TLR4, or TLR9 mice fed with vehicle alone (Fig 2, A) . DNFB gavage efficiently prevented the CHS response in TLR2
, and B6 mice but did not tolerize TLR4 2/2 mice, although a slight decrease in ear swelling was observed (Fig 2, A) , possibly reflecting a regulatory effect of other innate pattern recognition receptors or the existence of a non-TLR dependent component in oral tolerance. Accordingly, compared with control vehicle-fed animals, the capacity of hapten-specific T cells to proliferate and produce IFN-g was decreased by means of DNFB gavage in B6, TLR2
2/2
, and TLR9 2/2 mice but not TLR4 2/2 mice (Fig 2,  B) . These data show that TLR4 is required for induction of oral tolerance to DNFB.
Oral tolerance relies on expression of TLR4 on hematopoietic cells TLR4 is constitutively expressed on several types of both hematopoietic and nonhematopoietic cells, including gut epithelial cells. 26 To test the relative importance of TLR4 expression on radiosensitive hematopoietic cells and radioresistant nonhematopoietic cells for oral tolerance induction, we used 4 types of BM chimeric mice. As shown in Fig 2, C , suppression of the priming of specific IFN-g-producing CD8
1 T cells in skin dLNs by means of DNFB gavage reached 70% to 80% in B6 or TLR4 2/2 recipient mice reconstituted with B6 BM cells (B6-TLR4 2/2 and B6-B6 chimeras). In contrast, only modest suppression (20% to 30%) was achieved in full TLR4-deficient (TLR4 2/2 -TLR4
) chimeric mice and in mice lacking TLR4 on hematopoietic cells only (TLR4 2/2 -B6). This indicates that induction of oral tolerance to DNFB relies particularly on TLR4 expression on hematopoietic cells.
Oral tolerance can be transferred by MLN DCs, and this requires TLR4
Oral tolerance to protein antigens critically requires myeloidtype migratory intestinal DCs, which transport antigens from the gut lamina propria to MLNs 10 and express TLR4. 27 To investigate The CHS response to hapten DNFB in specific-pathogen free (SPF) and GF mice was determined each day for 4 days (A) and at 48 hours (B) after DNFB challenge. Results show means 6 SEMs of ear swelling (Fig 1, A) and values for individual mice (Fig 1, B) obtained from 2 experiments (n 5 7-10 mice per group). i.g, Intra-gastric. *P 5 .01 to .05 and ***P < . T cells in skin dLNs in response to a subsequent DNFB skin sensitization (Fig 3, A) and experienced a similar ear-swelling response after hapten challenge (Fig 3, B) . In contrast, both responses were inhibited by transfer of MLN DCs from DNFB-fed B6 but not TLR4 2/2 mice (Fig 3) , showing that DCs from MLNs of hapten-fed mice can transfer tolerance to DNFB and that their tolerogenic function critically relies on TLR4 expression.
TLR4 conditions migration of CD103
1 DCs in MLNs in response to hapten gavage Intestinal DCs sampling intestinal antigens constantly migrate at steady state from the lamina propria through LNs to MLNs.
These migratory DCs express CD103, and high levels of MHC-II molecules can present oral protein antigens to T cells 28, 29 and express the vitamin A-metabolizing enzyme RALDH, which is required for their tolerogenic function.
11,12 Thus we explored whether DNFB gavage affected DC subset dynamics in MLNs. Flow cytometric analysis revealed that DNFB gavage rapidly increased the frequency of migratory MHC-II hi DCs in MLNs (Fig 4, A) , without major changes in expression of the costimulatory (CD40, CD70, CD80, and CD86) or coinhibitory (B7-H1 and B7-DC) molecules (data not shown). Interestingly, the DNFB-induced increase essentially concerned the CD103 1 DC subset and was dependent on TLR4 expression (Fig 4, B) . In addition, the ALDEFLUOR assay revealed that DNFB gavage augmented the frequency and number of RALDH 1 migratory DCs in MLNs of B6 mice but not TLR4 2/2 mice (Fig 4, C and  D) . These data show that DNFB gavage induces mobilization of migratory CD103
1 DCs expressing RALDH to MLNs and that TLR4 is required for such dynamic.
TLR4 is required for hapten presentation to T cells by migratory DCs
To examine whether DCs mobilized by hapten gavage had also captured DNFB, we used an ex vivo hapten presentation assay with hapten-specific CD8 1 T cells as responders. 30 Interestingly, unfractionated CD11c
1 DCs from DNFB-fed B6 but not TLR4
2/2
mice induced hapten-specific CD8 1 T-cell proliferation (Fig 5, A,  left) , whereas DCs of both origin induced comparable T-cell proliferation when pulsed in vitro with the hapten (Fig 5, A, right) . T-cell proliferation was best induced by CD103 
CD11b
1 DCs compared with CD103 
2 or CD103 2 DCs from B6 but not TLR4 2/2 mice (Fig 5, B) . These data indicate that migratory CD103 
1 DCs mobilized to MLNs in a TLR4-dependent way by means of DNFB gavage also transport and present the hapten to T cells.
TLR4 deficiency impairs conversion of Foxp3 1 Treg cells by MLN DCs
Thanks to the presence of RALDH-expressing CD103 1 DCs, MLNs are an essential site for neoconversion of Foxp3 1 Treg cells, 11 which control local and systemic DTH responses to dietary antigens. 9 To determine whether TLR4 conditions the ability of MLN DCs to induce Treg cells during oral tolerance, we T
Oral tolerance to DNFB requires TLR4. A, CHS response at 48 hours after DNFB challenge in vehicle-or DNFB-fed B6 or TLR-deficient mice. Pooled data are from 3 experiments. B, DNFB-specific response in vehicle-or DNFB-fed B6 and TLR-deficient mice analyzed by using the IFN-g ELISpot and the tritiated thymidine proliferation test (mean 6 SEM; n 5 4-8). C, Suppression of DNFB-specific IFN-g-secreting cells induced by DNFB feeding in B6-TLR4 2/2 BM chimeric mice (mean 6 SEM; n 5 3-5). *P 5 .01 to .05, **P 5 .001 to .01, and ***P < .001. ns, P > .05.
cultured FACS-sorted MLN DCs from DNFB-fed B6 or TLR4
2/2 mice with purified Foxp3-eGFP 2 CD4 1 T cells in the presence of anti-CD3 mAb and active TGF-b and monitored generation of Foxp3 1 Treg cells. In this setting both types of DC induced similar frequencies of Foxp3 1 Treg cells (Fig 5, C) . As expected from previous work, 31 Foxp3 1 Treg cell conversion in cocultures of B6 DCs and CD4
1 T cells was less efficient in the presence of latent TGF-b compared with active TGF-b. Remarkably, DCs from hapten-fed TLR4 2/2 mice were poorly efficient at inducing Foxp3 1 Treg cell differentiation in the presence of latent TGF-b (Fig 5, C) . These data indicate that TLR4 expression critically conditions the capacity of MLN DCs to induce Foxp3 1 Treg cell conversion in the presence of latent TGF-b during oral tolerance to DNFB.
DISCUSSION
In this study we demonstrate that induction of oral tolerance to DNFB and efficient prevention of ACD in mice involves a major microbiota-dependent component and critically relies on TLR4 expression. Indeed, oral tolerance, as revealed by inhibition of hapten-specific CD8
1 T-cell priming and of the ear-swelling response after skin sensitization, is dramatically impaired in GF mice and in TLR4, but not TLR2 or TLR9, knockout mice. The fact that a slight yet barely significant decrease of the CHS response is observed in GF and TLR4-deficient mice likely reveals the existence of a minor microbiota-and TLR4-independent component in oral tolerance to DNFB. Our data using chimeric mice further revealed that oral tolerance requires TLR4 expression primarily on hematopoietic cells and that a selective deficiency of TLR4 on nonhematopoietic cells has no major effects. Previous studies using gavage with sodium dextran sulfate have documented a critical role of TLR4 and TLR2 in gut epithelial cells for sensing bacterial flora components and maintenance of intestinal homeostasis in the colon. 15 Our present data might indicate that similar sensing of the indigenous flora in the small intestine could preferentially involve TLR4-expressing hematopoietic cells.
We previously documented that shortly after intragastric delivery, DNFB translocates through duodenal epithelial cells, transiently associates with myeloid cells in the lamina propria, and then becomes no longer detectable by 24 hours, which is compatible with emigration of hapten-carrying DCs from the gut to the MLNs. 25 Using adoptive transfer experiments, flow (Fig 4, A) and DC subsets in CD11c 1 MHC-II 1 cells (Fig 4, B) . 
CD103
1 DCs also exhibited the highest efficacy to present DNFB to specific CD8 1 T cells ex vivo, indicating that the TLR4-dependent migration of this subset from the gut to the MLNs is coincident with oral tolerance induction. This is consistent with previous studies documenting that the major TLR4 ligand LPS induces loss of podosomes by DCs 32 and promotes the emigration of lamina propria DCs into mesenteric lymph. 33 Importantly, MLN DCs from hapten-fed B6 but not TLR4 2/2 mice were able to transfer tolerance to naive recipients. Such TLR4-dependent conditioning of DC tolerogenic functions is reminiscent to the observation that TLR4 engagement on CD103
1
DCs increases the expression of indolamine 2,3-dioxygenase, 34 which contributes to oral tolerance by regulating the ratio of effector T cells to Treg cells. 35 This suggests an intrinsic role of TLR4 signaling on DCs for their emigration from the gut and acquisition of suppressive functions during oral tolerance. Alternatively, it cannot be excluded that these effects might require the contribution of other TLR4-expressing hematopoietic cells populating the gut. These might include CXC3CR1 1 macrophages, which capture intestinal antigens 36 and transfer them to neighboring CD103 1 DCs for oral tolerance induction. 21 The respective role of TLR4 expressed by DCs versus other hematopoietic cells in oral tolerance remains to be determined.
We provide evidence that MLN DCs from hapten-fed TLR4-deficient mice display a reduced proportion of RALDHexpressing cells and an impaired capacity to efficiently convert naive CD4
1 T cells into Foxp3 1 Treg cells in the presence of latent TGF-b. Our preliminary analysis of CD103 1 MLN DCs from TLR4-sufficient versus TLR4-deficient mice did not reveal any difference of mRNA levels of the b8 integrin nor of matrix metalloproteinase 14 (data not shown), which are both expressed by CD103
1 DCs and contribute to cleavage of latent TGF-b. 31, 37 Altogether, our ex vivo data suggest that the critical role of TLR4 signaling in oral tolerance to DNFB primarily relies on induction of Foxp3 1 Treg cells by promoting the migration in MLNs of CD103
1 DCs able to produce retinoic acid thanks to RALDH expression and to activate latent TGF-b through mechanisms that remain to be determined. Oral tolerance to DNFB is critically dependent on Treg cells, 5, 6 but whether it requires a TLR4-dependent neodifferentiation of Treg cells remains a difficult question to address, given the difficulty of distinguishing induced from constitutive Treg cells in the absence of hapten-specific T-cell receptor transgenic models. Indeed, we could not find any significant changes in the frequency, absolute numbers, and phenotype (including expression of inducible costimulator, cytotoxic T lymphocyte-associated antigen 4, Ki67, and Helios) of Foxp3
1 Treg cells in MLNs after DNFB gavage in either B6 or TLR4 2/2 mice (data not shown). Interestingly, we observed that oral tolerance to OVA, as assessed by means of inhibition of skin DTH, 25 is intact in TLR4 2/2 mice (data not shown). This indicates that although TLR4 signaling is essential for the efficient suppression of CHS responses induced by prior gastrointestinal exposure to haptens, it is dispensable for the inhibition of DTH responses, which requires multiple feeding and relatively high doses of protein. cocultivated with total MLN DCs (Fig 5, A) or DC subsets (Fig 5, B) from DNFB-fed B6 or TLR4 2/2 mice. Thus it is likely that the requirement of TLR4 signaling for induction of oral tolerance depends on the type of target T cell (CD4 for protein-induced DTH vs CD8 for hapten-induced CHS) and/or the nature of the antigen (protein vs hapten). At variance with innocuous proteins, such as OVA, haptens like DNFB can covalently bind to endogenous and exogenous proteins and can trigger innate effector mechanisms and stress responses, 38 which could favor microbiota/immune cells interactions and TLR4 signaling to promote oral tolerance. The proinflammatory properties of hapten might indeed induce discrete modifications of gut permeability, resulting in translocation of microbiotaderived LPS and release of endogenous TLR4 ligands, such as low-molecular-weight hyaluronic acid, 39 a component of the extracellular matrix that promotes TLR4-dependent gut homeostasis. 40 Finally, a hapten like DNFB can bind to microbiota components, such as LPS, the signaling of which through TLR4 on myeloid cells could account for the TLR4 dependency of oral tolerance.
Taken together, our data demonstrate that oral tolerance to haptens relies critically on TLR4 expression on hematopoietic cells, which conditions mobilization of migratory CD103
1 DCs and hapten presentation to T cells for efficient control of CD8
T cell-mediated DTH responses and ACD. These findings might open up new avenues for oral biotherapeutic interventions using TLR4 ligands for protection against ACD.
